Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
Link to record
Permanent link

Direct link
Publications (10 of 69) Show all publications
Khandagale, A., Corcoran, P., Nikpour, M., Isaksson, A., Wikström, G., Siegbahn, A. & Christersson, C. (2022). MircoRNA in Extracellular Vesicles from Patients with Pulmonary Arterial Hypertension Alters Endothelial Angiogenic Response. International Journal of Molecular Sciences, 23(19), Article ID 11964.
Open this publication in new window or tab >>MircoRNA in Extracellular Vesicles from Patients with Pulmonary Arterial Hypertension Alters Endothelial Angiogenic Response
Show others...
2022 (English)In: International Journal of Molecular Sciences, ISSN 1661-6596, E-ISSN 1422-0067, Vol. 23, no 19, article id 11964Article in journal (Refereed) Published
Abstract [en]

Pulmonary arterial hypertension (PAH) is characterized by a progressive elevation of pulmonary pressure leading to right ventricular dysfunction and is associated with a poor prognosis. Patients with PAH have increased numbers of circulating extracellular vesicles (EVs) and altered expression of circulating microRNAs (miRs). The study aimed to evaluate the miR profile contained within purified EVs derived from the plasma of PAH patients as compared to healthy controls (HC). Circulating EVs, purified from platelet-free plasma were analyzed using flow cytometry, western blot, and electron microscopy. Total RNA isolated from EVs was subjected to Microarray analysis using GeneChip miRNA 4.0 Array and bioinformatics tools. Overexpression and inhibition of miRs were conducted in human pulmonary artery endothelial cells (hPAECs) that had been incubated previously with either PAH- or HC-derived EVs. Cell proliferation (MTT assay) and angiogenesis (tube formation assay) were tested in hPAECs to determine miR functionality. MiR profiling revealed 370 heats while comparing PAH and HC groups, 22 of which were found to be down-regulated and 6 were up-regulated in the PAH EVs. Among the altered miRs, miR-486-5p was overexpressed, while miR-26a-5p was downregulated in PAH EVs compared to HC EVs. Inhibition of mir-486-5p or overexpression of miR-26a-5p in hPAECs post-exposure of PAH EVs abrogated proangiogenic and proliferative effects posed by PAH EVs contrary to HC EVs. The angiogenic and proliferative effects of the miRs from PAH EVs were observed to be mediated through nuclear factor (NF)-kappa B activation. PAH EVs carry and present an altered miR profile that can be targeted to restrict angiogenesis and reduce pulmonary endothelium activation. Further studies concerning miRs from circulating heterogeneous EVs in PAH patients are warranted to understand their potential as targets for treatment in PAH.

Place, publisher, year, edition, pages
MDPI, 2022
Keywords
extracellular vesicles, microRNA, pulmonary arterial hypertension, pulmonary artery endothelial cells, miR-486-5p, miR-26a-5p, angiogenesis, proliferation
National Category
Cardiac and Cardiovascular Systems
Identifiers
urn:nbn:se:uu:diva-487291 (URN)10.3390/ijms231911964 (DOI)000867837900001 ()36233263 (PubMedID)
Funder
Swedish Research CouncilSwedish Heart Lung FoundationSwedish Foundation for Strategic ResearchMagnus Bergvall Foundation, 2021-04452Erik, Karin och Gösta Selanders Foundation
Available from: 2022-10-28 Created: 2022-10-28 Last updated: 2022-10-28Bibliographically approved
Gultekin, O., Gonzalez-Molina, J., Hardell, E., Moyano-Galceran, L., Mitsios, N., Mulder, J., . . . Carlson, J. W. (2021). FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation. npj Precision Oncology, 5(1), Article ID 97.
Open this publication in new window or tab >>FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation
Show others...
2021 (English)In: npj Precision Oncology, E-ISSN 2397-768X, Vol. 5, no 1, article id 97Article in journal (Refereed) Published
Abstract [en]

Uterine sarcomas are rare but deadly malignancies without effective treatment. Immunotherapy is a promising new approach to treat these tumors but has shown heterogeneous effects in sarcoma patients. With the goal of identifying key factors for improved patient treatment, we characterized the tumor immune landscape in 58 uterine sarcoma cases with full clinicopathological annotation. Immune cell characterization revealed the overall prevalence of FOXP3+ cells and pro-tumor M2-like macrophages. Hierarchical clustering of patients showed four tumor type-independent immune signatures, where infiltration of FOXP3+ cells and M1-like macrophages associated with favorable prognosis. High CD8+/FOXP3+ ratio in UUS and ESS correlated with poor survival, upregulation of immunosuppressive markers, extracellular matrix (ECM)-related genes and proteins, and YAP activation. This study shows that uterine sarcomas present distinct immune signatures with prognostic value, independent of tumor type, and suggests that targeting the ECM could be beneficial for future treatments.

Place, publisher, year, edition, pages
Springer NatureSpringer Nature, 2021
National Category
Cancer and Oncology Cell and Molecular Biology
Identifiers
urn:nbn:se:uu:diva-460086 (URN)10.1038/s41698-021-00236-6 (DOI)000720650900001 ()34799669 (PubMedID)
Funder
Swedish Cancer Society, 200169FSwedish Cancer Society, 201128PjSwedish Cancer Society, 2018/858Swedish Cancer Society, 2017/473Swedish Research Council, 2019-01541Swedish Childhood Cancer Foundation, TJ2019-0100The Cancer Research Funds of Radiumhemmet, 141082
Available from: 2021-12-14 Created: 2021-12-14 Last updated: 2024-01-15Bibliographically approved
Koster, J., Arbajian, E., Viklund, B., Isaksson, A., Hofvander, J., Haglund, F., . . . Mertens, F. (2020). Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development. Cancer Genetics, 241, 34-41
Open this publication in new window or tab >>Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development
Show others...
2020 (English)In: Cancer Genetics, ISSN 2210-7762, E-ISSN 2210-7770, Vol. 241, p. 34-41Article in journal (Refereed) Published
Abstract [en]

The dermatofibrosarcoma protuberans family of tumors (DPFT) comprises cutaneous soft tissue neoplasms associated with aberrant PDGFBR signaling, typically through a COL1A1-PDGFB fusion. The aim of the present study was to obtain a better understanding of the chromosomal origin of this fusion and to assess the spectrum of secondary mutations at the chromosome and nucleotide levels. We thus investigated 42 tumor samples from 35 patients using chromosome banding, fluorescence in situ hybridization, single nucleotide polymorphism arrays, and/or massively parallel sequencing (gene panel, whole exome and transcriptome sequencing) methods. We confirmed the age-associated differences in the origin of the COL1A1-PDGFB fusion and could show that it in most cases must arise after DNA synthesis, i.e., in the S or G2 phase of the cell cycle. Whereas there was a non-random pattern of secondary chromosomal rearrangements, single nucleotide variants seem to have little impact on tumor progression. No clear genomic differences between low-grade and high-grade DPFT were found, but the number of chromosomes and chromosomal imbalances as well as the frequency of 9p deletions all tended to be greater among the latter. Gene expression profiling of tumors with COL1A1-PDGFB fusions associated with unbalanced translocations or ring chromosomes identified several transcriptionally up-regulated genes in the amplified regions of chromosomes 17 and 22, including TBX2, PRKCA, MSI2, SOX9, SOX10, and PRAME.

Place, publisher, year, edition, pages
ELSEVIER SCIENCE INC, 2020
Keywords
Dermatofibrosarcoma, Fusion, SNP-array, RNA-seq, Translocation mechanisms
National Category
Medical Genetics Cancer and Oncology
Identifiers
urn:nbn:se:uu:diva-407718 (URN)10.1016/j.cancergen.2019.12.001 (DOI)000518200700005 ()31870844 (PubMedID)
Funder
Swedish Cancer SocietySwedish Childhood Cancer Foundation
Available from: 2020-06-10 Created: 2020-06-10 Last updated: 2023-09-07Bibliographically approved
Enblad, M., Graf, W., Terman, A., Pucholt, P., Viklund, B., Isaksson, A. & Birgisson, H. (2019). Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases. Annals of Surgical Oncology, 26, 4835-4842
Open this publication in new window or tab >>Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases
Show others...
2019 (English)In: Annals of Surgical Oncology, ISSN 1068-9265, E-ISSN 1534-4681, Vol. 26, p. 4835-4842Article in journal (Refereed) Published
Abstract [en]

Purpose: Genetic alterations in colorectal peritoneal metastases (PM) are largely unknown. This study was designed to analyze whole-genome copy number alterations (CNA) in colorectal PM and to identify alterations associated with prognosis after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

Methods: All patients with PM, originating from a colorectal adenocarcinoma, who were treated with CRS and HIPEC in Uppsala Sweden, between 2004 and 2015, were included (n = 114). DNA derived from formalin-fixed paraffin-embedded (FFPE) specimens were analyzed for CNA using molecular inversion probe arrays.

Results: There were extensive but varying degrees of CNA, ranging from minimal CNA to total aneuploidy. In particular, gain of parts of chromosome 1p and major parts of 15q were associated with poor survival. A combination of gains of 1p and 15q was associated with poor survival, also after adjustment for differences in peritoneal cancer index and completeness of cytoreduction score [hazard ratio (HR) 5.96; 95% confidence interval (CI) 2.19-16.18]. These patients had a mean copy number (CN) of 3.19 compared with 2.24 in patients without gains. Complete CN analysis was performed in 53 patients. Analysis was unsuccessful for the remaining patients due to insufficient amounts of DNA and signals caused by interstitial components and normal cells. There was no difference in survival between patients with successful and unsuccessful CN analysis.

Conclusions: This study shows that gains of parts of chromosome 1p and of major parts of chromosome 15q were significantly associated with poor survival after CRS and HIPEC, which could represent future prognostic biomarkers.

Place, publisher, year, edition, pages
Springer Nature, 2019
National Category
Surgery Cancer and Oncology
Identifiers
urn:nbn:se:uu:diva-404693 (URN)10.1245/s10434-019-07923-6 (DOI)000490648100005 ()31620944 (PubMedID)
Funder
Swedish Cancer Society, 150767Swedish Cancer Society, 150276Uppsala University
Available from: 2020-02-27 Created: 2020-02-27 Last updated: 2022-09-01Bibliographically approved
Binzer-Panchal, A., Hardell, E., Viklund, B., Ghaderi, M., Bosse, T., Nucci, M. R., . . . Carlson, J. W. (2019). Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes. Clinical Cancer Research, 25(7), 2155-2165
Open this publication in new window or tab >>Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes
Show others...
2019 (English)In: Clinical Cancer Research, ISSN 1078-0432, E-ISSN 1557-3265, Vol. 25, no 7, p. 2155-2165Article in journal (Refereed) Published
Abstract [en]

Purpose: Undifferentiated uterine sarcomas (UUS) are rare, extremely deadly, sarcomas with no effective treatment. The goal of this study was to identify novel intrinsic molecular UUS subtypes using integrated clinical, histopathologic, and molecular evaluation of a large, fully annotated, patient cohort.

Experimental Design: Fifty cases of UUS with full clinicopathologic annotation were analyzed for gene expression (n = 50), copy-number variation (CNV, n = 40), cell morphometry (n = 39), and protein expression (n = 22). Gene ontology and network enrichment analysis were used to relate over-and underexpressed genes to pathways and further to clinicopathologic and phenotypic findings.

Results: Gene expression identified four distinct groups of tumors, which varied in their clinicopathologic parameters. Gene ontology analysis revealed differential activation of pathways related to genital tract development, extracellular matrix (ECM), muscle function, and proliferation. A multivariable, adjusted Cox proportional hazard model demonstrated that RNA group, mitotic index, and hormone receptor expression influence patient overall survival (OS). CNV arrays revealed characteristic chromosomal changes for each group. Morphometry demonstrated that the ECM group, the most aggressive, exhibited a decreased cell density and increased nuclear area. A cell density cutoff of 4,300 tumor cells per mm(2) could separate ECM tumors from the remaining cases with a sensitivity of 83% and a specificity of 94%. IHC staining of MMP-14, Collagens 1 and 6, and Fibronectin proteins revealed differential expression of these ECM-related proteins, identifying potential new biomarkers for this aggressive sarcoma subgroup. Conclusions: Molecular evaluation of UUS provides novel insights into the biology, prognosis, phenotype, and possible treatment of these tumors.

Place, publisher, year, edition, pages
AMER ASSOC CANCER RESEARCH, 2019
National Category
Cancer and Oncology
Identifiers
urn:nbn:se:uu:diva-382512 (URN)10.1158/1078-0432.CCR-18-2792 (DOI)000462991900019 ()30617134 (PubMedID)
Funder
The Cancer Research Funds of RadiumhemmetSwedish Cancer SocietyMagnus Bergvall FoundationStockholm County Council
Available from: 2019-04-30 Created: 2019-04-30 Last updated: 2019-04-30Bibliographically approved
Sole, M., Ablondi, M., Binzer, A., Velie, B. D., Hollfelder, N., Buys, N., . . . Lindgren, G. (2019). Inter- and intra-breed genome-wide copy number diversity in a large cohort of European equine breeds. BMC Genomics, 20(1), Article ID 759.
Open this publication in new window or tab >>Inter- and intra-breed genome-wide copy number diversity in a large cohort of European equine breeds
Show others...
2019 (English)In: BMC Genomics, E-ISSN 1471-2164, Vol. 20, no 1, article id 759Article in journal (Refereed) Published
Abstract [en]

Background Copy Number Variation (CNV) is a common form of genetic variation underlying animal evolution and phenotypic diversity across a wide range of species. In the mammalian genome, high frequency of CNV differentiation between breeds may be candidates for population-specific selection. However, CNV differentiation, selection and its population genetics have been poorly explored in horses. Results We investigated the patterns, population variation and gene annotation of CNV using the Axiom (R) Equine Genotyping Array (670,796 SNPs) from a large cohort of individuals (N = 1755) belonging to eight European horse breeds, varying from draught horses to several warmblood populations. After quality control, 152,640 SNP CNVs (individual markers), 18,800 segment CNVs (consecutive SNP CNVs of same gain/loss state or both) and 939 CNV regions (CNVRs; overlapping segment CNVs by at least 1 bp) compared to the average signal of the reference (Belgian draught horse) were identified. Our analyses showed that Equus caballus chromosome 12 (ECA12) was the most enriched in segment CNV gains and losses (similar to 3% average proportion of the genome covered), but the highest number of segment CNVs were detected on ECA1 and ECA20 (regardless of size). The Friesian horses showed private SNP CNV gains (> 20% of the samples) on ECA1 and Exmoor ponies displayed private SNP CNV losses on ECA25 (> 20% of the samples). The Warmblood cluster showed private SNP CNV gains located in ECA9 and Draught cluster showed private SNP CNV losses located in ECA7. The length of the CNVRs ranged from 1 kb to 21.3 Mb. A total of 10,612 genes were annotated within the CNVRs. The PANTHER annotation of these genes showed significantly under- and overrepresented gene ontology biological terms related to cellular processes and immunity (Bonferroni P-value < 0.05). We identified 80 CNVRs overlapping with known QTL for fertility, coat colour, conformation and temperament. We also report 67 novel CNVRs. Conclusions This work revealed that CNV patterns, in the genome of some European horse breeds, occurred in specific genomic regions. The results provide support to the hypothesis that high frequency private CNVs residing in genes may potentially be responsible for the diverse phenotypes seen between horse breeds.

Place, publisher, year, edition, pages
BMC, 2019
Keywords
Copy number variation, Horse, Structural variation, SNP genotyping array
National Category
Genetics Genetics and Breeding in Agricultural Sciences
Identifiers
urn:nbn:se:uu:diva-397040 (URN)10.1186/s12864-019-6141-z (DOI)000491861300003 ()31640551 (PubMedID)
Funder
Swedish Research Council Formas, 2016-00947
Available from: 2019-11-20 Created: 2019-11-20 Last updated: 2024-01-17Bibliographically approved
Hofvander, J., Viklund, B., Isaksson, A., Brosjo, O., von Steyern, F. V., Rissler, P., . . . Mertens, F. (2018). Different patterns of clonal evolution among different sarcoma subtypes followed for up to 25 years. Nature Communications, 9, Article ID 3662.
Open this publication in new window or tab >>Different patterns of clonal evolution among different sarcoma subtypes followed for up to 25 years
Show others...
2018 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 9, article id 3662Article in journal (Refereed) Published
Abstract [en]

To compare clonal evolution in tumors arising through different mechanisms, we selected three types of sarcoma-amplicon-driven well-differentiated liposarcoma (WDLS), gene fusion-driven myxoid liposarcoma (MLS), and sarcomas with complex genomes (CXS)-and assessed the dynamics of chromosome and nucleotide level mutations by cytogenetics, SNP array analysis and whole-exome sequencing. Here we show that the extensive single-cell variation in WDLS has minor impact on clonal key amplicons in chromosome 12. In addition, only a few of the single nucleotide variants in WDLS were present in more than one lesion, suggesting that such mutations are of little significance in tumor development. MLS displays few mutations other than the FUS-DDIT3 fusion, and the primary tumor is genetically sometimes much more complex than its relapses, whereas CXS in general shows a gradual increase of both nucleotide- and chromosome-level mutations, similar to what has been described in carcinomas.

National Category
Medical Genetics
Identifiers
urn:nbn:se:uu:diva-365649 (URN)10.1038/s41467-018-06098-0 (DOI)000444078300005 ()30201954 (PubMedID)
Funder
Swedish Cancer Society, CAN2017/269
Available from: 2018-11-14 Created: 2018-11-14 Last updated: 2023-03-28Bibliographically approved
Karlsson, J., Valind, A., Mengelbier, L. H., Bredin, S., Cornmark, L., Jansson, C., . . . Gisselsson, D. (2018). Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer. Nature Genetics, 50(7), 944-950
Open this publication in new window or tab >>Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
Show others...
2018 (English)In: Nature Genetics, ISSN 1061-4036, E-ISSN 1546-1718, Vol. 50, no 7, p. 944-950Article in journal (Refereed) Published
Abstract [en]

A major challenge to personalized oncology is that driver mutations vary among cancer cells inhabiting the same tumor. Whether this reflects principally disparate patterns of Darwinian evolution in different tumor regions has remained unexplored(1-5). We mapped the prevalence of genetically distinct clones over 250 regions in 54 childhood cancers. This showed that primary tumors can simultaneously follow up to four evolutionary trajectories over different anatomic areas. The most common pattern consists of subclones with very few mutations confined to a single tumor region. The second most common is a stable coexistence, over vast areas, of clones characterized by changes in chromosome numbers. This is contrasted by a third, less frequent, pattern where a clone with driver mutations or structural chromosome rearrangements emerges through a clonal sweep to dominate an anatomical region. The fourth and rarest pattern is the local emergence of a myriad of clones with TP53 inactivation. Death from disease was limited to tumors exhibiting the two last, most dynamic patterns.

Place, publisher, year, edition, pages
NATURE PUBLISHING GROUP, 2018
National Category
Medical Genetics
Identifiers
urn:nbn:se:uu:diva-361111 (URN)10.1038/s41588-018-0131-y (DOI)000437224400009 ()29867221 (PubMedID)
Funder
Swedish Research Council, 2016-01022Swedish Cancer Society, CAN2015/284Swedish Childhood Cancer Foundation, PR2016-024Swedish Childhood Cancer Foundation, NCP2015-0035
Available from: 2018-09-21 Created: 2018-09-21 Last updated: 2018-09-21Bibliographically approved
Danesi, C., Achuta, V. S., Corcoran, P., Peteri, U.-K., Turconi, G., Matsui, N., . . . Castren, M. L. (2018). Increased Calcium Influx through L-type Calcium Channels in Human and Mouse Neural Progenitors Lacking Fragile X Mental Retardation Protein. Stem Cell Reports, 11(6), 1449-1461
Open this publication in new window or tab >>Increased Calcium Influx through L-type Calcium Channels in Human and Mouse Neural Progenitors Lacking Fragile X Mental Retardation Protein
Show others...
2018 (English)In: Stem Cell Reports, ISSN 2213-6711, Vol. 11, no 6, p. 1449-1461Article in journal (Refereed) Published
Abstract [en]

The absence of FMR1 protein (FMRP) causes fragile X syndrome (FXS) and disturbed FMRP function is implicated in several forms of human psychopathology. We show that intracellular calcium responses to depolarization are augmented in neural progenitors derived from human induced pluripotent stem cells and mouse brain with FXS. Increased calcium influx via nifedipine-sensitive voltage-gated calcium (Ca-v) channels contributes to the exaggerated responses to depolarization and type 1 metabotropic glutamate receptor activation. The ratio of L-type/T-type Ca-v channel expression is increased in FXS progenitors and correlates with enhanced progenitor differentiation to glutamate-responsive cells. Genetic reduction of brain-derived neurotrophic factor in FXS mouse progenitors diminishes the expression of Ca-v channels and activity-dependent responses, which are associated with increased phosphorylation of the phospholipase C-gamma 1 site within TrkB receptors and changes of differentiating progenitor subpopulations. Our results show developmental effects of increased calcium influx via L-type Ca-v channels in FXS neural progenitors.

National Category
Cell and Molecular Biology Neurosciences
Identifiers
urn:nbn:se:uu:diva-372938 (URN)10.1016/j.stemcr.2018.11.003 (DOI)000452898300016 ()30503263 (PubMedID)
Available from: 2019-01-10 Created: 2019-01-10 Last updated: 2019-01-10Bibliographically approved
Gunnarsson, R., DiLorenzo, S., Lundin-Ström, K. B., Olsson, L., Biloglav, A., Lilljebjörn, H., . . . Johansson, B. (2018). Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia. Leukemia, 32(10), 2117-2125
Open this publication in new window or tab >>Mutation, methylation, and gene expression profiles in dup(1q)-positive pediatric B-cell precursor acute lymphoblastic leukemia
Show others...
2018 (English)In: Leukemia, ISSN 0887-6924, E-ISSN 1476-5551, Vol. 32, no 10, p. 2117-2125Article in journal (Refereed) Published
Abstract [en]

High-throughput sequencing was applied to investigate the mutation/methylation patterns on 1q and gene expression profiles in pediatric B-cell precursor acute lymphoblastic leukemia (BCP ALL) with/without (w/wo) dup(1q). Sequencing of the breakpoint regions and all exons on 1q in seven dup(1q)-positive cases revealed non-synonymous somatic single nucleotide variants (SNVs) in BLZF1, FMN2, KCNT2, LCE1C, NES, and PARP1. Deep sequencing of these in a validation cohort w (n = 17)/wo (n = 94) dup(1q) revealed similar SNV frequencies in the two groups (47% vs. 35%; P = 0.42). Only 0.6% of the 36,259 CpGs on 1q were differentially methylated between cases w (n = 14)/wo (n = 13) dup(1q). RNA sequencing of high hyperdiploid (HeH) and t(1;19)(q23;p13)-positive cases w (n = 14)/wo (n = 52) dup(1q) identified 252 and 424 differentially expressed genes, respectively; only seven overlapped. Of the overexpressed genes in the HeH and t(1;19) groups, 23 and 31%, respectively, mapped to 1q; 60-80% of these encode nucleic acid/protein binding factors or proteins with catalytic activity. We conclude that the pathogenetically important consequence of dup(1q) in BCP ALL is a gene-dosage effect, with the deregulated genes differing between genetic subtypes, but involving similar molecular functions, biological processes, and protein classes.

Place, publisher, year, edition, pages
Nature Publishing Group, 2018
National Category
Medical Genetics
Identifiers
urn:nbn:se:uu:diva-367402 (URN)10.1038/s41375-018-0092-2 (DOI)000446171800003 ()29626196 (PubMedID)
Funder
Swedish Research Council, 2016-01084Swedish Cancer Society, CAN 2017/291Swedish Childhood Cancer Foundation, PR2015-0006
Available from: 2018-12-03 Created: 2018-12-03 Last updated: 2018-12-03Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0001-6576-7825

Search in DiVA

Show all publications